Table 4 Acute STI diagnoses made at GUM clinic visit(s) between 1 May 2006 and 30 April 2007, by country of birth/origin: women
CEE countriesAll other countries (including UK/Ireland)
Denominator131115 223
% (95% CI) (n)% (95% CI) (n)p ValueAge-adjusted OR† (95% CI)p Value*
1+Acute STI14.4% (12.6% to 16.4%) (189)15.7% (15.1% to 16.3%) (2391)0.2170.87 (0.74 to 1.02)0.090
HIV0.0% (0)0.2% (0.1% to 0.3%) (28)0.120N/AN/A
Gonorrhoea0.9% (0.5% to 1.6%) (12)0.8% (0.7% to 1.0%) (128)0.7781.08 (0.60 to 1.97)0.790
Chlamydia6.9% (5.6% to 8.4%) (90)6.1% (5.7% to 6.4%) (922)0.2411.12 (0.90 to 1.41)0.317
Syphilis0.0% (0)0.05% (0.02% to 0.1%) (8)0.406N/AN/A
HSV (first attack)0.8% (0.4% to 1.4%) (10)1.7% (1.5% to 2.0%) (265)0.0080.44 (0.23 to 0.83)0.011
Genital warts (first attack)2.3% (1.5% to 3.3%) (30)3.5% (3.2% to 3.8%) (529)0.0230.64 (0.44 to 0.92)0.017
Trichomonas0.4% (0.1% to 0.9%) (5)1.1% (0.9% to 1.3%) (164)0.0160.38 (0.15 to 0.92)0.033
Family planning23.9% (21.6% to 26.3%) (313)12.4% (11.9% to 13.0%) (1892)<0.0012.33 (2.02 to 2.68)<0.001
  • *p Value for comparison between visits made by patients from central and eastern European (CEE) countries and patients from all other countries.

  • †Age-adjusted odds ratio (OR) for patients from CEE countries relative to patients from all other countries.

  • GUM, genitourinary medicine; HSV, herpes simplex virus; STI, sexually transmitted infection.